![]() |
ACRS | Aclaris Therapeutics, Inc. |
Pharmaceutical Preparations |
Book value per $ invested | $ 2.75 |
Leverage | 28.74% |
Market Cap | $ 165.3m |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -129.2m |
Margin | -452.92% |
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a line of novel small molecule therapeutics to address the needs of patients with immuno-inflammatory diseases. The company is headquartered in Wayne, Pennsylvania.